By Regulatory Approvals — AbbVie Seeks EMA Approval for SKYRIZI Subcutaneous Induction in Crohn’s Disease The Clinical Trial Vanguard
Read the original at Regulatory Approvals ↗
Auto-published by the finit.news Events monitor from Regulatory Approvals; summarized by AI and may contain errors — verify against the primary source. August 27, 2026.